Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05712772
Other study ID # STUDY22040093
Secondary ID R21MH127294
Status Recruiting
Phase N/A
First received
Last updated
Start date June 14, 2023
Est. completion date July 31, 2024

Study information

Verified date September 2023
Source University of Pittsburgh
Contact Adriane M Soehner, PhD
Phone 4122466651
Email soehneram2@upmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this neuroimaging pilot study is to understand developmental differences in the impact of therapeutic wavelength light (blue light) versus a non-therapeutic wavelength (red light) on emotional brain function in depression. The main questions this study aims to answer are: - Does acute exposure to blue light (vs red light) stabilize emotional brain function in depressed individuals? - Are stabilizing effects of blue light (vs red light) stronger for blue light in adolescents than young adults? Participants will complete: - A magnetic resonance imaging brain scan, in which we will examine the effect of blue versus red light on emotional brain function at rest and in response to rewards and losses. - A pupillometry test of sensitivity to blue vs red light - Clinical interviews and surveys - Screening measures for drug and alcohol use, MRI safety, and current pregnancy [if relevant] - Home sleep tracking with sleep diary and actigraphy for one week


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date July 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers No
Gender All
Age group 12 Years to 30 Years
Eligibility Inclusion Criteria: - DSM-5 major depressive episode - (If <18yr) Parent or guardian can attend the baseline clinical interview Exclusion Criteria: - Unable to read and write in English - Intellectual disability. - Left or mixed handedness - Use of psychotropic medication other than stable Selective Serotonin Reuptake Inhibitor (SSRI) medication (> 2 months) - Lifetime bipolar disorder or schizophrenia, or substance/alcohol disorder in the past 3 months. - Factors influencing light and color sensitivity (i.e., color-blindness, serious ophthalmological conditions, photo-sensitizing medication). - Factors influencing the ability to maintain a stable sleep schedule (i.e., shift work, severe sleep disorders, extremely late or early sleep schedule). - Severe medical illness, neurological disorders, or history of head trauma. - Current pregnancy or nursing - MRI contraindication (e.g., metals in the body, recent tattoo, claustrophobia) - Positive alcohol or substance use screen at MRI visit

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Blue Light
Blue light exposure
Red Light
Red light exposure

Locations

Country Name City State
United States Western Psychiatric Hospital Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Amygdala cerebral blood flow during Blue vs Red light exposure Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the amygdala region of interest will be examined. Collected during the blue and red light exposures during the MRI scan at the lab visit
Primary Ventral Striatum cerebral blood flow during Blue vs Red light exposure Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the ventral striatum region of interest will be examined. Collected during the blue and red light exposures during the MRI scan at the lab visit
Primary Amygdala activity (loss>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within an amygdala region of interest on loss versus neutral (no win/no loss) trials. Collected during the blue and red light exposures during the MRI scan at the lab visit
Primary Ventral Striatum activity (punish>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within a ventral striatum region of interest on win versus neutral (no win/no loss) trials. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Medial prefrontal cortex cerebral blood flow during Blue vs Red light exposure Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the medial prefrontal region of interest will be examined. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Insula cerebral blood flow during Blue vs Red light exposure Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the insula regions of interest will be examined. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Ventromedial prefrontal cortex cerebral blood flow during Blue vs Red light exposure Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the ventromedial prefrontal cortex regions of interest will be examined. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Amygdala-whole brain functional connectivity (loss>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Functional connectivity is defined as a psychophysiological interaction between the seed region (amygdala) and the whole brain on loss versus neutral (no win/no loss) trials Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Ventromedial prefrontal cortex activity (loss>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within the ventromedial prefrontal cortex region of interest on loss versus neutral (no win/no loss) trials. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Insula activity (loss>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within the insula region of interest on loss versus neutral (no win/no loss) trials. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Medial prefrontal cortex activity (win>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within the medial prefrontal region of interest on win versus neutral (no win/no loss) trials. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Ventral striatum-whole brain functional connectivity (win>neutral) during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Functional connectivity is defined as a psychophysiological interaction between the seed region (ventral striatum) and the whole brain. Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Ventromedial prefrontal cortex activity, insula, and medial prefrontal activity, and amygdala- and ventral striatum whole brain functional connectivity (response bias; B') during Blue vs Red light exposure This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within the above regions of interest using a response bias metric (B'). Functional connectivity is defined as a psychophysiological interaction between the seed regions (amygdala, ventral striatums) and the whole brain. Collected during the blue and red light exposures during the MRI scan at the lab visit
See also
  Status Clinical Trial Phase
Recruiting NCT05965401 - Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents N/A
Recruiting NCT05437588 - Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents N/A
Recruiting NCT04719897 - Life Experiences in Adolescents and the Development of Skills N/A
Active, not recruiting NCT05376358 - Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents N/A
Recruiting NCT05691439 - Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function N/A
Recruiting NCT06139861 - Better Sleep Study N/A
Recruiting NCT04747340 - Clinical Effectiveness of TARA Compared to Standard Treatment for Adolescents and Young Adults With Depression N/A
Recruiting NCT06273995 - Telehealth Behavioral Activation for Teens N/A
Completed NCT06213142 - Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health N/A
Recruiting NCT05329441 - Inflammatory and Glutamatergic Mechanisms of Sustained Threat in Adolescents With Depression
Completed NCT05300204 - Evaluation of a Website to Improve Depression Literacy in Adolescents With Depression N/A
Completed NCT05300217 - Evaluation of a Website to Improve Depression Literacy in Adoldescents N/A
Recruiting NCT06193772 - Increasing Treatment Response Rates in Depressed Adolescents Via Feedback-Informed IPDT N/A
Completed NCT05335564 - Evaluation of a Website to Improve Depression Literacy in Parents of Adolescents With Depression N/A
Completed NCT05326178 - Evaluation of a Website to Improve Depression Literacy in Parents of Healthy Adolescents N/A
Completed NCT04719949 - Shaping Actions and Responses to Emotions N/A
Not yet recruiting NCT05865834 - Improvement of Mental Health in Adolescents Using E-health Interventions N/A
Recruiting NCT06387108 - Evaluation of a Training Course for Educational Professionals N/A
Not yet recruiting NCT05804877 - Online MBCT Program for University Students N/A
Recruiting NCT05617495 - Mindfulness-Based fMRI Neurofeedback for Depression N/A